On ECHEMI
Home > Drugs > Systemic lupus erythematosus
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple systems and organs and has multiple autoantibodies. Tissue damage is caused by a large number of pathogenic autoantibodies and immune complexes in the body. Clinically, there may be manifestations of damage to various systems and organs, such as skin, joints, serous membranes, heart, kidneys, central nervous system, blood system, etc. The disease occurs worldwide, with a prevalence of 4/100,000 to 25/100,000. The prevalence is higher in Asia and blacks, and the prevalence in my country is 70/100,000 to 75/100,000. The incidence in women is significantly higher than that in men, about 10:1. The peak incidence is in women of childbearing age, and the elderly and children may also be ill. This disease belongs to the category of Yin-Yang poison, Yang poison spot, butterfly spot, sunburn sore, ghost face sore, and face wandering wind in traditional Chinese medicine.
  • Site of disease:

    Immune system
  • Infectious :

    Not contagious
  • Frequent population:

    Women aged 15 to 40
  • Related symptoms:

    Discoid erythema joint pain myalgia fever fatigue
Related Drugs
Thymopentin for injection
Indication: This product is suitable for: malignant tumor patients with low immune function caused by radiotherapy and chemotherapy. (1) For patients with chronic hepatitis B over 18 years old. (2) Various primary or secondary T cell deficiency diseases (such as congenital immunodeficiency in children). (3) Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.). (Lupus erythematosus is an autoimmune disease with a slow onset and insidious occurrence. The clinical manifestations are diverse and varied. It is an autoimmune disease involving many systems and organs. Due to the dysfunction of cellular and humoral immune function, a variety of autoantibodies are produced. It can affect the skin, serous membranes, joints, kidneys and central nervous system, etc., and is characterized by autoimmunity. There are multiple autoantibodies in the patient's body, which not only affect humoral immunity, but also cellular immunity, and the complement system also changes. The pathogenesis is mainly due to the formation of immune complexes. The exact cause is unknown. The condition is a process of repeated attacks and remissions.) (4) Various diseases with low cellular immune function. (5) Adjuvant treatment of tumors.
Manufacturer:

Beijing SL Pharmaceutical Co., Ltd.

Thymopentin for injection
Indication: This product is suitable for: malignant tumor patients with low immune function caused by radiotherapy and chemotherapy. (1) For patients with chronic hepatitis B over 18 years old. (2) Various primary or secondary T cell deficiency diseases (such as congenital immunodeficiency in children). (3) Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.). (Lupus erythematosus is an autoimmune disease with a slow onset and insidious occurrence. The clinical manifestations are diverse and varied. It is an autoimmune disease involving many systems and organs. Due to the dysfunction of cellular and humoral immune function, a variety of autoantibodies are produced. It can affect the skin, serous membranes, joints, kidneys and central nervous system, etc., and is characterized by autoimmunity. There are multiple autoantibodies in the patient's body, which not only affect humoral immunity, but also cellular immunity, and the complement system also changes. The pathogenesis is mainly due to the formation of immune complexes. The exact cause is unknown. The condition is a process of repeated attacks and remissions.) (4) Various diseases with low cellular immune function. (5) Adjuvant treatment of tumors.
Manufacturer:

Chengdu Shengnuo Biopharm Co., Ltd.

Thymopentin for injection
Indication: This product is suitable for: malignant tumor patients with low immune function caused by radiotherapy and chemotherapy. (1) For patients with chronic hepatitis B over 18 years old. (2) Various primary or secondary T cell deficiency diseases (such as congenital immunodeficiency in children). (3) Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.). (Lupus erythematosus is an autoimmune disease with a slow onset and insidious occurrence. The clinical manifestations are diverse and varied. It is an autoimmune disease involving many systems and organs. Due to the dysfunction of cellular and humoral immune function, a variety of autoantibodies are produced. It can affect the skin, serous membranes, joints, kidneys and central nervous system, etc., and is characterized by autoimmunity. There are multiple autoantibodies in the patient's body, which not only affect humoral immunity, but also cellular immunity, and the complement system also changes. The pathogenesis is mainly due to the formation of immune complexes. The exact cause is unknown. The condition is a process of repeated attacks and remissions.) (4) Various diseases with low cellular immune function. (5) Adjuvant treatment of tumors.
Recombinant human interleukin-2 (Ⅰ) for injection
Indication: Used for the treatment of congenital or acquired immunodeficiency, improving the patient's cellular immune function and anti-infection ability. Treatment of various autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, etc. It has a certain therapeutic effect on certain viral, bacillary diseases, and intracellular parasitic infectious diseases, such as hepatitis B, leprosy, tuberculosis, and Candida albicans infection. Used in combination with chemotherapy and radiotherapy to enhance the therapeutic effect and improve immunity. Used for anti-recurrence and anti-metastasis treatment after surgery, chemotherapy and radiotherapy of malignant tumors, and at the same time enhance immunity. Treat malignant pleural, abdominal and pericardial effusions. Used for biological immunotherapy of tumors that are not suitable for surgery, chemotherapy and radiotherapy.
Manufacturer:

Beijing Shougang Gas Company Limited

Recombinant human interleukin-2 (Ⅰ) for injection
Indication: Used for the treatment of congenital or acquired immunodeficiency, improving the patient's cellular immune function and anti-infection ability. Treatment of various autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, etc. It has a certain therapeutic effect on certain viral, bacillary diseases, and intracellular parasitic infectious diseases, such as hepatitis B, leprosy, tuberculosis, and Candida albicans infection. Used in combination with chemotherapy and radiotherapy to enhance the therapeutic effect and improve immunity. Used for anti-recurrence and anti-metastasis treatment after surgery, chemotherapy and radiotherapy of malignant tumors, and at the same time enhance immunity. Treat malignant pleural, abdominal and pericardial effusions. Used for biological immunotherapy of tumors that are not suitable for surgery, chemotherapy and radiotherapy.
Manufacturer:

Beijing Shougang Gas Company Limited

Thymopentin injection
Indication: For chronic hepatitis B patients over 18 years old. Because the thymus begins to atrophy after 18 years old, the cellular immune function is reduced. 2 Various primary or secondary T cell deficiency diseases. 3 Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.). 4 Various diseases with low cellular immune function. 5 Adjuvant treatment of tumors.
Manufacturer:

Hainan Zhonghe Pharmaceutical Co., Ltd.

Thymopentin injection
Indication: 1 For chronic hepatitis B patients over 18 years old. Because the thymus begins to shrink after 18 years old, the cellular immune function is reduced. 2 Various primary or secondary T cell deficiency diseases. 3 Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.). 4 Various diseases with low cellular immune function. 5 Adjuvant treatment of tumors.
Manufacturer:

Beijing Sciecure Pharmaceutical Co., Ltd.

Thymopentin injection
Indication: For chronic hepatitis B patients over 18 years old. Because the thymus begins to atrophy after 18 years old, the cellular immune function is reduced. 2 Various primary or secondary T cell deficiency diseases. 3 Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.). 4 Various diseases with low cellular immune function. 5 Adjuvant treatment of tumors.
Manufacturer:

Hainan Zhonghe Pharmaceutical Co., Ltd.

Danazol Capsules
Indication: It is used to treat endometriosis, and can also be used to treat fibrocystic breast disease, spontaneous thrombocytopenic purpura, hereditary angioedema, systemic erythema, male gynecomastia, and precocious puberty.
Danazol Capsules
Indication: It is used to treat endometriosis, and can also be used to treat fibrocystic breast disease, spontaneous thrombocytopenic purpura, hereditary angioedema, systemic erythema, male gynecomastia, and precocious puberty.
Manufacturer:

Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.